- Home
- CCBG vs CTMX Comparison
CCBG vs CTMX Comparison
Compare CCBG & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCBG | CTMX |
|---|---|---|
| Founded | 1895 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.7M | 596.2M |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CCBG | CTMX |
|---|---|---|
| Price | $41.72 | $4.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $45.00 | $11.90 |
| AVG Volume (30 Days) | 77.4K | ★ 8.7M |
| Earning Date | 04-20-2026 | 03-16-2026 |
| Dividend Yield | ★ 2.47% | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | ★ 3.60 | N/A |
| Revenue | N/A | ★ $76,201,000.00 |
| Revenue This Year | $6.25 | N/A |
| Revenue Next Year | $3.17 | $27.22 |
| P/E Ratio | ★ $11.72 | $22.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $32.38 | $0.40 |
| 52 Week High | $46.83 | $8.21 |
Technical Indicators
Market Signals| Indicator | CCBG | CTMX |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 45.48 |
| Support Level | $41.65 | $3.55 |
| Resistance Level | $41.86 | $6.20 |
| Average True Range (ATR) | 1.08 | 0.60 |
| MACD | -0.07 | -0.05 |
| Stochastic Oscillator | 29.50 | 6.75 |
Price Performance
Historical ComparisonAbout CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.